Department of Physiology and Hypertension and Renal Center of Excellence, Tulane Univ. Health Sciences Center, New Orleans, LA 70112, USA.
Am J Physiol Renal Physiol. 2011 Sep;301(3):F574-9. doi: 10.1152/ajprenal.00065.2011. Epub 2011 Jun 22.
Recent studies in smooth muscle-specific Na(+)/Ca(2+) exchanger-1 knockout (NCX1(sm-/-)) mice reveal reduced arterial pressure and impaired myogenic responses compared with heterozygous littermates. In this study, we determined renal function in male anesthetized NCX1(sm-/-) mice and NCX1 heterozygous (NCX1(+/-)) littermates before and during acute ANG II infusions. Systolic blood pressure in awake mice was lower in NCX1(sm-/-) mice compared with NCX1(+/-) mice (119 ± 4 vs. 131 ± 3 mmHg, P < 0.05). Acute ANG II infusions (5 ng·min(-1)·g(-1) body wt) increased mean arterial pressure in anesthetized NCX1(+/-) (109 ± 2 to 134 ± 3 mmHg, P < 0.001, n = 8) and NCX1(sm-/-) (101 ± 8 to 129 ± 8 mmHg, P < 0.01, n = 6) mice to a similar extent (Δ25 ± 1 vs. Δ28 ± 4 mmHg, P > 0.05). In response to ANG II infusions, PAH clearance (C(PAH)) decreased from 1.39 ± 0.27 to 0.98 ± 0.22 ml·min(-1)·g(-1) (P < 0.05) and glomerular filtration rate (GFR) was reduced from 0.50 ± 0.09 to 0.32 ± 0.06 ml·min(-1)·g(-1) (P < 0.05) in NCX1(+/-) mice. In contrast, the NCX1(sm-/-) did not exhibit significant reductions in either C(PAH) (1.16 ± 0.30 to 1.22 ± 0.34 ml·min(-1)·g(-1), P > 0.05) or GFR (0.48 ± 0.08 to 0.41 ± 0.05 ml·min(-1)·g(-1), P > 0.05) during acute ANG II infusions. Using flometry to measure renal blood flow continuously, NCX1(sm-/-) mice had significantly attenuated responses to ANG II infusions (-34.2 ± 3.9%, P < 0.05) compared with those in NCX1(+/-) mice (-48 ± 2%) or in wild-type mice (-69 ± 7%). These data indicate that renal vascular responses to ANG II are attenuated in NCX1(sm-/-) mice compared with NCX1(+/-) mice and that NCX1 contributes to the renal vasoconstriction response to acute ANG II infusions.
最近的研究表明,与杂合子同窝仔相比,平滑肌特异性钠/钙交换体 1 敲除(NCX1(sm-/-))小鼠的动脉血压降低,血管平滑肌的收缩反应受损。在这项研究中,我们在麻醉状态下检测雄性 NCX1(sm-/-)小鼠和 NCX1 杂合子(NCX1(+/-))同窝仔的肾功能,同时给予急性血管紧张素 II 输注。清醒状态下的 NCX1(sm-/-)小鼠的收缩压较 NCX1(+/-)同窝仔低(119 ± 4 对 131 ± 3mmHg,P < 0.05)。急性血管紧张素 II 输注(5ng·min-1·g-1 体重)使麻醉状态下的 NCX1(+/-)(109 ± 2 对 134 ± 3mmHg,P < 0.001,n = 8)和 NCX1(sm-/-)(101 ± 8 对 129 ± 8mmHg,P < 0.01,n = 6)小鼠的平均动脉压增加到相似的程度(Δ25 ± 1 对 Δ28 ± 4mmHg,P > 0.05)。在血管紧张素 II 输注反应中,PAH 清除率(C(PAH))从 1.39 ± 0.27 降至 0.98 ± 0.22ml·min-1·g-1(P < 0.05),肾小球滤过率(GFR)从 0.50 ± 0.09 降至 0.32 ± 0.06ml·min-1·g-1(P < 0.05)。相反,NCX1(sm-/-)在急性血管紧张素 II 输注过程中,C(PAH)(1.16 ± 0.30 对 1.22 ± 0.34ml·min-1·g-1,P > 0.05)或 GFR(0.48 ± 0.08 对 0.41 ± 0.05ml·min-1·g-1,P > 0.05)均无明显下降。使用血流计连续测量肾血流量,与 NCX1(+/-)小鼠(-48 ± 2%)或野生型小鼠(-69 ± 7%)相比,NCX1(sm-/-)小鼠对血管紧张素 II 输注的反应明显减弱(-34.2 ± 3.9%,P < 0.05)。这些数据表明,与 NCX1(+/-)小鼠相比,NCX1(sm-/-)小鼠对血管紧张素 II 的肾脏血管反应减弱,而 NCX1 有助于急性血管紧张素 II 输注引起的肾脏血管收缩反应。